Myriad Genetics (NASDAQ: MYGN) has announced a collaboration with Flatiron Health to integrate its MyRisk®...
Accessible
Myriad Genetics, Inc.Myriad’s MyRisk® test is the first hereditary cancer test integrated into Flatiron’s OncoEMR®SALT LAKE CITY, Oct. 15, 2024 (GLOBE...